Scope Fluidics S.A.

Warsaw Stock Exchange SCP.WA

Scope Fluidics S.A. Debt to Equity Ratio for the year ending December 31, 2023: 0.03

Scope Fluidics S.A. Debt to Equity Ratio is 0.03 for the year ending December 31, 2023, a 303.72% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Scope Fluidics S.A. Debt to Equity Ratio for the year ending December 31, 2022 was 0.01, a -99.20% change year over year.
Scope Fluidics S.A. Debt to Equity Ratio for the year ending December 31, 2021 was 0.92, a 195.77% change year over year.
Scope Fluidics S.A. Debt to Equity Ratio for the year ending December 31, 2020 was 0.31, a 490.13% change year over year.
Scope Fluidics S.A. Debt to Equity Ratio for the year ending December 31, 2019 was 0.05, a 0.00% change year over year.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

Warsaw Stock Exchange: SCP.WA

Scope Fluidics S.A.

CEO	Mr. Piotr Garstecki
IPO Date	Aug. 1, 2017
Location	Poland
Headquarters	9th floor
Employees	40
Sector	Healthcare
Industries Biotechnology Medical Instruments

Description

Scope Fluidics S.A., a biotechnology company, engages in the designing and developing projects based on microfluidic technologies in medical diagnostics and healthcare. It offers BacterOMIC, an antibiotic susceptibility testing. The company was founded in 2010 and is based in Warsaw, Poland.

Key trends

Past 5 years